UniProt ID | SHC1_HUMAN | |
---|---|---|
UniProt AC | P29353 | |
Protein Name | SHC-transforming protein 1 | |
Gene Name | SHC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 583 | |
Subcellular Localization |
Cytoplasm. Isoform p46Shc: Mitochondrion matrix . Localized to the mitochondria matrix. Targeting of isoform p46Shc to mitochondria is mediated by its first 32 amino acids, which behave as a bona fide mitochondrial targeting sequence. Isoform p52Shc |
|
Protein Description | Signaling adapter that couples activated growth factor receptors to signaling pathways. Participates in a signaling cascade initiated by activated KIT and KITLG/SCF. Isoform p46Shc and isoform p52Shc, once phosphorylated, couple activated receptor tyrosine kinases to Ras via the recruitment of the GRB2/SOS complex and are implicated in the cytoplasmic propagation of mitogenic signals. Isoform p46Shc and isoform p52Shc may thus function as initiators of the Ras signaling cascade in various non-neuronal systems. Isoform p66Shc does not mediate Ras activation, but is involved in signal transduction pathways that regulate the cellular response to oxidative stress and life span. Isoform p66Shc acts as a downstream target of the tumor suppressor p53 and is indispensable for the ability of stress-activated p53 to induce elevation of intracellular oxidants, cytochrome c release and apoptosis. The expression of isoform p66Shc has been correlated with life span (By similarity). Participates in signaling downstream of the angiopoietin receptor TEK/TIE2, and plays a role in the regulation of endothelial cell migration and sprouting angiogenesis.. | |
Protein Sequence | MDLLPPKPKYNPLRNESLSSLEEGASGSTPPEELPSPSASSLGPILPPLPGDDSPTTLCSFFPRMSNLRLANPAGGRPGSKGEPGRAADDGEGIVGAAMPDSGPLPLLQDMNKLSGGGGRRTRVEGGQLGGEEWTRHGSFVNKPTRGWLHPNDKVMGPGVSYLVRYMGCVEVLQSMRALDFNTRTQVTREAISLVCEAVPGAKGATRRRKPCSRPLSSILGRSNLKFAGMPITLTVSTSSLNLMAADCKQIIANHHMQSISFASGGDPDTAEYVAYVAKDPVNQRACHILECPEGLAQDVISTIGQAFELRFKQYLRNPPKLVTPHDRMAGFDGSAWDEEEEEPPDHQYYNDFPGKEPPLGGVVDMRLREGAAPGAARPTAPNAQTPSHLGATLPVGQPVGGDPEVRKQMPPPPPCPGRELFDDPSYVNVQNLDKARQAVGGAGPPNPAINGSAPRDLFDMKPFEDALRVPPPPQSVSMAEQLRGEPWFHGKLSRREAEALLQLNGDFLVRESTTTPGQYVLTGLQSGQPKHLLLVDPEGVVRTKDHRFESVSHLISYHMDNHLPIISAGSELCLQQPVERKL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDLLPPKP -------CCCCCCCC | 8.06 | 22814378 | |
1 (in isoform 2) | Acetylation | - | 8.06 | 22814378 | |
1 (in isoform 7) | Acetylation | - | 8.06 | 22814378 | |
17 | Phosphorylation | YNPLRNESLSSLEEG CCCCCCCCHHHHHCC | 36.78 | 28348404 | |
19 | Phosphorylation | PLRNESLSSLEEGAS CCCCCCHHHHHCCCC | 42.00 | 28348404 | |
20 | Phosphorylation | LRNESLSSLEEGASG CCCCCHHHHHCCCCC | 45.13 | 28348404 | |
26 | Phosphorylation | SSLEEGASGSTPPEE HHHHCCCCCCCCCHH | 44.10 | 28348404 | |
28 | Phosphorylation | LEEGASGSTPPEELP HHCCCCCCCCCHHCC | 34.93 | 28348404 | |
29 | Phosphorylation | EEGASGSTPPEELPS HCCCCCCCCCHHCCC | 46.52 | 33259812 | |
33 | Ubiquitination | SGSTPPEELPSPSAS CCCCCCHHCCCCCHH | 72.29 | 29967540 | |
36 | Phosphorylation | TPPEELPSPSASSLG CCCHHCCCCCHHHCC | 44.08 | 16699171 | |
54 | Phosphorylation | PPLPGDDSPTTLCSF CCCCCCCCCCCHHHH | 28.96 | 16251354 | |
80 | Phosphorylation | PAGGRPGSKGEPGRA CCCCCCCCCCCCCCC | 39.92 | 28674419 | |
115 | Phosphorylation | LQDMNKLSGGGGRRT HHCHHHHCCCCCCCC | 36.68 | 25394399 | |
139 | Phosphorylation | EEWTRHGSFVNKPTR CCCCCCCCCCCCCCC | 21.64 | 29255136 | |
143 | Ubiquitination | RHGSFVNKPTRGWLH CCCCCCCCCCCCCCC | 42.33 | 29967540 | |
145 | Phosphorylation | GSFVNKPTRGWLHPN CCCCCCCCCCCCCCC | 43.34 | 20201521 | |
154 | Ubiquitination | GWLHPNDKVMGPGVS CCCCCCCCCCCCCHH | 40.54 | - | |
154 | Acetylation | GWLHPNDKVMGPGVS CCCCCCCCCCCCCHH | 40.54 | - | |
161 | Phosphorylation | KVMGPGVSYLVRYMG CCCCCCHHHHHHHHH | 20.75 | 23663014 | |
162 | Phosphorylation | VMGPGVSYLVRYMGC CCCCCHHHHHHHHHH | 13.55 | 23663014 | |
166 | Ubiquitination | GVSYLVRYMGCVEVL CHHHHHHHHHHHHHH | 7.15 | 29967540 | |
203 | Ubiquitination | CEAVPGAKGATRRRK HHHCCCCCCCCCCCC | 55.80 | - | |
203 (in isoform 6) | Ubiquitination | - | 55.80 | - | |
206 | Phosphorylation | VPGAKGATRRRKPCS CCCCCCCCCCCCCCC | 33.12 | - | |
211 | Ubiquitination | GATRRRKPCSRPLSS CCCCCCCCCCCCHHH | 21.36 | 29967540 | |
213 | Phosphorylation | TRRRKPCSRPLSSIL CCCCCCCCCCHHHHH | 45.52 | - | |
226 | Ubiquitination | ILGRSNLKFAGMPIT HHCCCCCEECCCEEE | 37.10 | - | |
237 | Phosphorylation | MPITLTVSTSSLNLM CEEEEEEECHHHHHH | 19.82 | 27251275 | |
238 | Phosphorylation | PITLTVSTSSLNLMA EEEEEEECHHHHHHH | 20.28 | 27251275 | |
239 | Phosphorylation | ITLTVSTSSLNLMAA EEEEEECHHHHHHHH | 25.89 | 27251275 | |
240 | Phosphorylation | TLTVSTSSLNLMAAD EEEEECHHHHHHHHH | 22.74 | 27251275 | |
280 | Ubiquitination | YVAYVAKDPVNQRAC HHHHHHCCCCCCCEE | 42.51 | 29967540 | |
296 | Ubiquitination | ILECPEGLAQDVIST EECCCCHHHHHHHHH | 3.54 | 24816145 | |
307 | Ubiquitination | VISTIGQAFELRFKQ HHHHHHHHHHHHHHH | 8.48 | 24816145 | |
313 | Ubiquitination | QAFELRFKQYLRNPP HHHHHHHHHHHHCCC | 31.44 | - | |
313 (in isoform 6) | Ubiquitination | - | 31.44 | - | |
315 | Phosphorylation | FELRFKQYLRNPPKL HHHHHHHHHHCCCCC | 14.28 | 28152594 | |
317 (in isoform 7) | Phosphorylation | - | 48.99 | 25627689 | |
318 (in isoform 7) | Phosphorylation | - | 55.41 | 25849741 | |
321 | Ubiquitination | QYLRNPPKLVTPHDR HHHHCCCCCCCCCHH | 57.77 | 29967540 | |
324 | Phosphorylation | RNPPKLVTPHDRMAG HCCCCCCCCCHHHCC | 25.91 | 21722762 | |
325 | Ubiquitination | NPPKLVTPHDRMAGF CCCCCCCCCHHHCCC | 21.65 | 29967540 | |
326 | Ubiquitination | PPKLVTPHDRMAGFD CCCCCCCCHHHCCCC | 26.41 | 29967540 | |
334 | Ubiquitination | DRMAGFDGSAWDEEE HHHCCCCCCCCCCCC | 19.59 | 24816145 | |
335 | Phosphorylation | RMAGFDGSAWDEEEE HHCCCCCCCCCCCCC | 28.20 | 21945579 | |
344 | Ubiquitination | WDEEEEEPPDHQYYN CCCCCCCCCCCCCCC | 42.79 | 24816145 | |
349 | Phosphorylation | EEPPDHQYYNDFPGK CCCCCCCCCCCCCCC | 10.79 | 21945579 | |
350 | Phosphorylation | EPPDHQYYNDFPGKE CCCCCCCCCCCCCCC | 11.16 | 21945579 | |
352 | Ubiquitination | PDHQYYNDFPGKEPP CCCCCCCCCCCCCCC | 34.69 | 24816145 | |
352 (in isoform 2) | Ubiquitination | - | 34.69 | 21906983 | |
353 | Ubiquitination | DHQYYNDFPGKEPPL CCCCCCCCCCCCCCC | 8.38 | 24816145 | |
380 | Phosphorylation | APGAARPTAPNAQTP CCCCCCCCCCCCCCC | 49.55 | 27050516 | |
386 | Phosphorylation | PTAPNAQTPSHLGAT CCCCCCCCCCCCCCC | 25.09 | 25159151 | |
388 | Phosphorylation | APNAQTPSHLGATLP CCCCCCCCCCCCCCC | 34.43 | 25159151 | |
393 | Phosphorylation | TPSHLGATLPVGQPV CCCCCCCCCCCCCCC | 29.78 | 23312004 | |
399 (in isoform 3) | Ubiquitination | - | 22.31 | 21906983 | |
426 | Phosphorylation | RELFDDPSYVNVQNL CCCCCCCCCCCCCCH | 49.02 | 22167270 | |
427 (in isoform 6) | Phosphorylation | - | 11.05 | 25627689 | |
427 | Phosphorylation | ELFDDPSYVNVQNLD CCCCCCCCCCCCCHH | 11.05 | 19664994 | |
428 (in isoform 6) | Phosphorylation | - | 7.12 | 25849741 | |
435 | Ubiquitination | VNVQNLDKARQAVGG CCCCCHHHHHHHHCC | 48.94 | 29967540 | |
436 | Ubiquitination | NVQNLDKARQAVGGA CCCCHHHHHHHHCCC | 14.42 | 29967540 | |
444 | Ubiquitination | RQAVGGAGPPNPAIN HHHHCCCCCCCCCCC | 41.28 | 24816145 | |
445 | Ubiquitination | QAVGGAGPPNPAING HHHCCCCCCCCCCCC | 25.59 | 24816145 | |
453 | Phosphorylation | PNPAINGSAPRDLFD CCCCCCCCCCHHHCC | 30.52 | 9488479 | |
454 | Ubiquitination | NPAINGSAPRDLFDM CCCCCCCCCHHHCCC | 12.44 | 24816145 | |
462 (in isoform 1) | Ubiquitination | - | 48.69 | 21906983 | |
462 | Ubiquitination | PRDLFDMKPFEDALR CHHHCCCCCHHHHHC | 48.69 | 21906983 | |
463 | Ubiquitination | RDLFDMKPFEDALRV HHHCCCCCHHHHHCC | 31.08 | 24816145 | |
471 | Ubiquitination | FEDALRVPPPPQSVS HHHHHCCCCCCCCCC | 29.28 | 24816145 | |
472 | Ubiquitination | EDALRVPPPPQSVSM HHHHCCCCCCCCCCH | 50.80 | 24816145 | |
494 | Phosphorylation | PWFHGKLSRREAEAL CCCCCCCCHHHHHHH | 32.55 | - | |
513 | Phosphorylation | GDFLVRESTTTPGQY CCEEEEECCCCCCEE | 22.08 | 25159151 | |
514 | Phosphorylation | DFLVRESTTTPGQYV CEEEEECCCCCCEEE | 29.90 | 25159151 | |
515 | Phosphorylation | FLVRESTTTPGQYVL EEEEECCCCCCEEEE | 40.03 | 25159151 | |
516 | Phosphorylation | LVRESTTTPGQYVLT EEEECCCCCCEEEEE | 26.05 | 25159151 | |
520 | Phosphorylation | STTTPGQYVLTGLQS CCCCCCEEEEEECCC | 11.89 | 28152594 | |
558 | Phosphorylation | SVSHLISYHMDNHLP CHHHHHHHHHCCCCC | 8.31 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
29 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
54 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
139 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
194 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
194 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
195 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
195 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
206 | T | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
213 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
239 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PSP |
239 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
239 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
239 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
240 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PSP |
240 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
240 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
240 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
272 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
272 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
317 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
317 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PSP |
317 | Y | Phosphorylation | Kinase | NTRK1 | P04629 | GPS |
317 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
317 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
317 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
317 | Y | Phosphorylation | Kinase | PTK2 | P34152-2 | GPS |
349 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PhosphoELM |
349 | Y | Phosphorylation | Kinase | SYK | P43405 | GPS |
349 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
349 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
349 | Y | Phosphorylation | Kinase | FLT4 | P35916 | GPS |
350 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PhosphoELM |
350 | Y | Phosphorylation | Kinase | SYK | P43405 | GPS |
350 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
350 | Y | Phosphorylation | Kinase | FLT4 | P35916 | GPS |
350 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
386 | T | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
410 | Y | Phosphorylation | Kinase | JAK3 | P52333 | PSP |
427 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PhosphoELM |
427 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
427 | Y | Phosphorylation | Kinase | FLT4 | P35916 | GPS |
427 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
427 | Y | Phosphorylation | Kinase | SYK | P43405 | GPS |
427 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
448 | Y | Phosphorylation | Kinase | JAK3 | P52333 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
36 | S | Phosphorylation |
| 15837797 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SHC1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-426 AND TYR-427, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND TYR-427, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND TYR-427, ANDMASS SPECTROMETRY. | |
"The Shc adaptor protein is highly phosphorylated at conserved, twintyrosine residues (Y239/240) that mediate protein-proteininteractions."; van der Geer P., Wiley S., Gish G.D., Pawson T.; Curr. Biol. 6:1435-1444(1996). Cited for: PHOSPHORYLATION AT TYROSINE RESIDUES. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-427, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-349 AND TYR-427, ANDMASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-349; TYR-350 ANDTYR-427, AND MASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-427, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-349; TYR-350 ANDTYR-427, AND MASS SPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-349; TYR-350 ANDTYR-427, AND MASS SPECTROMETRY. | |
"Profiling of tyrosine phosphorylation pathways in human cells usingmass spectrometry."; Salomon A.R., Ficarro S.B., Brill L.M., Brinker A., Phung Q.T.,Ericson C., Sauer K., Brock A., Horn D.M., Schultz P.G., Peters E.C.; Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-427, AND MASSSPECTROMETRY. |